March 2017: the company stock officially listed on the Shenzhen Stock Exchange's gem edition.

September 2015: Company postdoctoral research workstation approved.

February 2015: the company completed the shareholding system transformation, the enterprise name changed to "Jiangxi Synergy Pharmaceutical Co., Ltd. "".

November 2014: the company "Jiangxi special raw material engineering technology research center" was approved.

November 2012: the company passed the EU-GMP on-site review for the first time.

November 2011: the new integrated office building is completed and put into use.

February 2010: the company was first reviewed by the Japanese PMDA-GMP.

November 2009: the company passed the China SFDA on-site GMP inspection for the first time.

September 2009: the company for the first time through the U. S. FDA on-site GMP inspection.

January 2007: the company passed the Korean KFDA on-site GMP inspection for the first time.

May 2006: obtain drug production license.

February 2005: laying the foundation stone for construction.

April 2004: Jiangxi Tonghe Pharmaceutical Co., Ltd. was formally established.